Systems Oncology has a total of 37 patents globally, out of which 1 have been granted. Of these 37 patents, more than 56% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Systems Oncology.
Systems Oncology was founded in 2015. Systems oncology creates cancer therapeutics to hasten the conversion of scientific discoveries into ground-breaking cancer treatments.
Do read about some of the most popular patents of Systems Oncology which have been covered by us in this article and also you can find Systems Oncology patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Systems Oncology patent portfolio.
How many patents do the Founder and CEO of Systems Oncology have?
The Founder Chris Yoo have 0 patents, Spyro Mousses (Also CEO) have 59 patents.
How many patents does Systems Oncology have?
Systems Oncology has a total of 37 patents globally. These patents belong to 4 unique patent families. Out of 37 patents, 21 patents are active.
How Many Patents did Systems Oncology File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Systems Oncology Applications Filed | Systems Oncology Patents Granted |
| 2022 | 4 | – |
| 2021 | 10 | – |
| 2019 | 11 | 1 |
| 2018 | 2 | – |
| 2017 | 10 | – |
How many Systems Oncology patents are Alive/Dead?
Worldwide Patents
How Many Patents did Systems Oncology File in Different Countries?
Countries in which Systems Oncology Filed Patents
| Country | Patent |
| United States Of America | 3 |
| Europe | 3 |
| Canada | 3 |
| Australia | 3 |
| Brazil | 2 |
| Mexico | 2 |
| Korea (South) | 2 |
| South Africa | 2 |
| China | 2 |
| India | 2 |
| Japan | 2 |
| Israel | 2 |
| Russia | 1 |
| Hong Kong (S.A.R.) | 1 |
Where are Research Centers of Systems Oncology Patents Located?
The Research Centers of Systems Oncology Patents is the United States of America.
List of Systems Oncology patents
| Sinovation Medical Patent | Title |
| US20230114305A1 | Recombinant Myxoma Viruses And Uses Thereof |
| US20210196771A1 | Recombinant Myxoma Viruses And Uses Thereof |
| EP3837354A4 | Recombinant Myxoma Viruses And Uses Thereof |
| EP4106781A1 | Recombinant Myxoma Viruses And Uses Thereof |
| CN112771157A | Recombinant Myxoma Viruses And Uses Thereof |
| WO2022235971A9 | Compositions For Inhibiting Growth Of Targeted Cells |
| WO2022235957A3 | Multitargeting Rna Immunotherapy Compositions |
| WO2022235975A3 | Sirna Constructs For Inhibiting Gene Expression In Targeted Cancer Cells |
| WO2022235976A1 | Multitargeting Rna Compositions |
| AU2019321667A1 | Recombinant Myxoma Viruses And Uses Thereof |
| CA3168771A1 | Recombinant Myxoma Viruses And Uses Thereof |
| CA3109216A1 | Recombinant Myxoma Viruses And Uses Thereof |
| AU2021224730A1 | Recombinant Myxoma Viruses And Uses Thereof |
| ZA201808608B | Combination Chemotherapies |
| IL280854A | Recombinant Myxoma Viruses And Uses Thereof |
| MX2021001883A | Recombinant Myxoma Viruses And Uses Thereof. |
| IN202117008635A | Recombinant Myxoma Viruses And Uses Thereof |
| ZA202101019A | Recombinant Myxoma Viruses And Uses Thereof |
| JP2021533789A5 | Recombinant Myxoma Virus And Uses Thereof |
| KR1020210094509A | Recombinant Myxoma Virus And Uses Thereof |
| HK40048030A | Recombinant Myxoma Viruses And Uses Thereof |
| US20200179417A1 | Combination Chemotherapies |
| EP3558317A4 | Combination Chemotherapies |
| CN109689060A | Combination Chemotherapies |
| WO2020037206A4 | Recombinant Myxoma Viruses And Uses Thereof |
| WO2022032146A1 | Methods For Inhibiting Growth Of Era Positive Cancers |
| WO2018005279A1 | Combination Chemotherapies |
| AU2017291411A1 | Combination Chemotherapies |
| CA3029228A1 | Combination Chemotherapies |
| BR112021002639A2 | Recombinant Mixoma Viruses And Uses Thereof |
| IN201917003193A | Combination Chemotherapies |
| MX2018016332A | Combination Chemotherapies. |
| BR112018076639A2 | Combination Chemotherapies |
| IL263785A | Combination Chemotherapies |
| JP2019518795A | Combination Chemotherapy |
| KR1020190025646A | Combination Chemotherapy |
| RU2021106556A | Recombinant Myxoma Viruses And Their Applications |
What are Systems Oncology key innovation segments?
What Technologies are Covered by Eterne?
The chart below distributes patents filed by Systems Oncology